Le Lézard
Classified in: Health
Subject: SVY

Legal Cannabis Market 23.97% CAGR Growth Report by 2021 | ReportsnReports


PUNE, India, December 7, 2017 /PRNewswire/ --

Legal cannabis market trend is rising number of countries decriminalizing and legalizing cannabis. Legalization of marijuana has emerged as a rising trend, which is influencing many nations to decriminalize cannabis and legalize the use of marijuana both for recreational and medicinal purposes. At present, there are 29 states in the US that have legalized marijuana for medicinal purposes where eight states have been granted the permission for the use of marijuana both for recreational and medicinal purposes.

Complete report on Legal Cannabis Market spread across 107 pages, analyzing 17 major companies and providing 52 data exhibits now available at http://www.reportsnreports.com/reports/1245462-global-legal-cannabis-market-2017-2021.html .

The analysts forecast global legal cannabis market to grow at a CAGR of 23.97% during the period 2017-2021. According to the report, one driver in the legal cannabis market is growing social acceptance of cannabis. The perception of several nations has changed regarding cannabis from being merely an intoxicating drug to a business venture, which can prove to be highly profitable in the long run. Over past five years, the global legal cannabis market has repeatedly posted robust growth, alluring the new vendors and large investors to leverage the potential of this industry. The growth of cannabis market has significantly added to the income of several governments and boosted sales and revenues of major corporations. The rising popularity of recreational marijuana has provided traction to the global legal cannabis market.

Key players in the global legal cannabis market: Aurora Cannabis, Bhang Corporation, Canopy Growth Corporation, Medical Marijuana, and Mentor Capital. Other Prominent Vendors in the market are: Cannoid, CBD American Shaman, CV Sciences, Elixinol, FOLIUM BIOSCIENCES, IRIE CBD, Meadow Care, mCig, NuLeaf Naturals, Pharmahemp, Terra Tech, and United Cannabis. Cannabis is a flowering plant. Species of cannabis are Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Cannabis plants have many varieties, out of which two most prominent ones are marijuana and hemp. Predominantly, cannabis contains two cannabinoids tetrahydrocannabinol (THC) and cannabidiol (CBD). THC is highly psychoactive and causes intoxication. Order a copy of Global Legal Cannabis Market 2017-2021 report at http://www.reportsnreports.com/purchase.aspx?name=1245462 .

Further, the legal cannabis market report states that one challenge in the market is compromising public health. Legalizing cannabis in any country poses a great threat to its citizens as its over-consumption can lead to various respiratory problems and several health issues. Till 2015, there were nearly 15 countries in the world where marijuana was available for purchase from the commercial market, and in these countries, it was reported that approximately 50% of the people under the age of 18 years had easy access to marijuana products. Therefore, the population is exposed to use, misuse, and abuse of the substance, affecting the life of masses in vast numbers.

Another related report is Global Processed Snacks Market 2017-2021, the analysts forecast global processed snacks market to grow at a CAGR of 2.64% during the period 2017-2021. Key players are Aviko, Calbee, General Mills, Hormel Foods, Intersnack Group, Kellogg Company, McCain Foods, PepsiCo, and Tyson Foods. The other vendors in the market are Aviko and Lamb Weston.

A processed snack is altered from its original form through cooking, drying, salting, freezing, smoking, pickling, canning, baking, or drying during preparation. The global snacks market is set to grow at a moderate pace during the forecast period. It is segmented into salted snacks, bakery snacks, confectionery, frozen snacks, and other food products. The changes in consumer lifestyles, increasing disposable incomes, and increased demand for convenience foods have affected the market positively during the forecast period. Browse complete Processed Snacks Market report at http://www.reportsnreports.com/reports/1245477-global-processed-snacks-market-2017-2021.html .

Explore other new reports on Food and Beverages Market http://www.reportsnreports.com/market-research/food-and-beverages/ .

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
2nd Floor, Metropole Building
Next to Inox Theatre
Bund Garden Road, Pune - 411013.
Maharashtra, India
+1-888-391-5441
[email protected]

Connect with Us:  

LinkedIn: http://www.linkedin.com/company/reportsnreports

RSS/Feeds:  http: //http://www.reportsnreports.com/feed/l-latestreports.xml


SOURCE ReportsnReports


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: